M Viitasalo

Author PubWeight™ 50.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol 1994 3.35
2 Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001 3.34
3 Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 2007 1.98
4 Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998 1.77
5 Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999 1.68
6 Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999 1.59
7 A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol 2001 1.39
8 Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med 2009 1.35
9 Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens 2001 1.17
10 Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996 1.14
11 Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. Eur Heart J 1998 1.13
12 Torsades de pointes after terfenadine-itraconazole interaction. BMJ 1993 1.10
13 Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol 2001 1.10
14 QT interval as a cardiac risk factor in a middle aged population. Heart 1997 1.06
15 Effects of acute alcohol infusion on duration and dispersion of QT interval in male patients with coronary artery disease and in healthy controls. Clin Cardiol 1999 1.05
16 Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat 2000 1.02
17 Effects of toxic and non-toxic cyanobacteria on grazing, zooplanktivory and survival of the mysid shrimp Mysis mixta. J Exp Mar Bio Ecol 2001 1.01
18 Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol 2000 0.98
19 Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med 1997 0.98
20 Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol 1998 0.96
21 Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome. Heart 2001 0.95
22 Magnetocardiographic QT interval dispersion in postmyocardial infarction patients with sustained ventricular tachycardia: validation of automated QT measurements. Pacing Clin Electrophysiol 1998 0.95
23 Left ventricular function in children with the Marfan syndrome. Eur Heart J 1994 0.95
24 Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation. Am J Cardiol 1998 0.95
25 Effects of acute alcohol ingestion on heart rate variability in patients with documented coronary artery disease and stable angina pectoris. Am J Cardiol 1997 0.94
26 Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999 0.94
27 Fever and cardiac rhythm. Arch Intern Med 1986 0.92
28 Aortic distensibility in children with the Marfan syndrome. Am J Cardiol 1992 0.92
29 Electrocardiographic repolarization during stress from awakening on alarm call. J Am Coll Cardiol 1997 0.88
30 Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 1992 0.86
31 Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function. J Cardiovasc Pharmacol 2000 0.85
32 Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol 1993 0.85
33 Molecular genetics of the long QT syndrome: two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred. Hum Mutat 1998 0.84
34 QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 1999 0.83
35 QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997 0.83
36 Effect of light on the feeding rates of pelagic and littoral mysid shrimps: a trade-off between feeding success and predation avoidance. J Exp Mar Bio Ecol 2001 0.83
37 Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A. Am J Cardiol 2001 0.81
38 Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome. Clin Cardiol 1994 0.81
39 24-Hour electrocardiographic recordings in mild acute infectious myocarditis. Ann Clin Res 1984 0.80
40 Arrhythmias and ST segment deviation during prolonged exhaustive exercise (ski marathon) in healthy middle-aged men. Eur Heart J 1994 0.80
41 Left ventricular mass, geometry, and filling in endurance athletes: association with exercise blood pressure. J Appl Physiol (1985) 1997 0.79
42 Imbalance of the autonomic nervous system at night in women with gestational diabetes. Diabet Med 2010 0.78
43 Postmyocardial infarction patients susceptible to ventricular tachycardia show increased T wave dispersion independent of delayed ventricular conduction. J Cardiovasc Electrophysiol 2001 0.78
44 The performance of the probability density function in differentiating supraventricular from ventricular rhythms. Pacing Clin Electrophysiol 1992 0.77
45 Electrocardiographic assessment of left ventricular hypertrophy with time-voltage QRS and QRST-wave areas. J Hum Hypertens 2004 0.77
46 Electrocardiographic findings in female endurance athletes. Clin J Sport Med 1997 0.77
47 Electrocardiographic measures of ventricular repolarisation dispersion in patients with coronary artery disease susceptible to ventricular fibrillation. Heart 1998 0.75
48 QT interval predicting for coronary heart disease morbidity. Circulation 1995 0.75
49 Measurement of QT interval. J Am Coll Cardiol 1996 0.75
50 [The invasive treatment of ventricular arrhythmias]. Duodecim 1996 0.75
51 Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome. J Am Coll Cardiol 1998 0.75
52 [Hereditary polymorphic ventricular tachycardia as a cause of syncopes and sudden cardiac deaths]. Duodecim 2000 0.75
53 Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects. J Hum Hypertens 2001 0.75
54 Linkage of the long QT syndrome to the short arm of chromosome 11: use of five highly polymorphic markers towards more detailed localization of the mutant gene. Hum Genet 1995 0.75
55 Effects of cardiovascular autonomic function tests on QT dispersion in the 12-lead electrocardiogram of healthy patients. J Electrocardiol 2000 0.75
56 Magnetocardiographic QT dispersion during cardiovascular autonomic function tests. Basic Res Cardiol 2000 0.75
57 [To treat a cardiac arrest or to count ventricular arrhythmias?]. Duodecim 1994 0.75
58 [Idiopathic ventricular tachycardia]. Duodecim 1996 0.75
59 [Treating congestive heart failure with pacemaker]. Duodecim 2001 0.75
60 [Prevention of sudden death using implantable defibrillators]. Duodecim 1991 0.75
61 [Amiodarone: the most effective and the most problematic arrhythmia drug]. Duodecim 1990 0.75
62 [Surgical treatment of Wolff-Parkinson-White syndrome]. Duodecim 1992 0.75
63 [Arrhythmogenic right ventricular dysplasia and idiopathic tachycardia]. Duodecim 1991 0.75